nodes	percent_of_prediction	percent_of_DWPC	metapath
Disopyramide—SLC22A2—Memantine—Alzheimer's disease	0.363	0.652	CbGbCtD
Disopyramide—CYP3A4—Rivastigmine—Alzheimer's disease	0.0835	0.15	CbGbCtD
Disopyramide—CYP3A4—Donepezil—Alzheimer's disease	0.0667	0.12	CbGbCtD
Disopyramide—CYP3A4—Galantamine—Alzheimer's disease	0.043	0.0773	CbGbCtD
Disopyramide—KCND2—forebrain—Alzheimer's disease	0.00456	0.0693	CbGeAlD
Disopyramide—KCND2—telencephalon—Alzheimer's disease	0.00419	0.0637	CbGeAlD
Disopyramide—KCND3—forebrain—Alzheimer's disease	0.00398	0.0604	CbGeAlD
Disopyramide—KCND3—telencephalon—Alzheimer's disease	0.00366	0.0555	CbGeAlD
Disopyramide—KCND2—nervous system—Alzheimer's disease	0.00248	0.0376	CbGeAlD
Disopyramide—KCND2—central nervous system—Alzheimer's disease	0.00238	0.0362	CbGeAlD
Disopyramide—KCND2—cerebellum—Alzheimer's disease	0.00233	0.0354	CbGeAlD
Disopyramide—KCND3—nervous system—Alzheimer's disease	0.00216	0.0328	CbGeAlD
Disopyramide—KCND3—central nervous system—Alzheimer's disease	0.00208	0.0316	CbGeAlD
Disopyramide—CHRM2—forebrain—Alzheimer's disease	0.00203	0.0309	CbGeAlD
Disopyramide—KCND3—cerebellum—Alzheimer's disease	0.00203	0.0309	CbGeAlD
Disopyramide—Apnoea—Memantine—Alzheimer's disease	0.00201	0.00732	CcSEcCtD
Disopyramide—SLC22A1—forebrain—Alzheimer's disease	0.002	0.0303	CbGeAlD
Disopyramide—Hypercholesterolaemia—Donepezil—Alzheimer's disease	0.00199	0.00723	CcSEcCtD
Disopyramide—Creatinine increased—Donepezil—Alzheimer's disease	0.00197	0.00718	CcSEcCtD
Disopyramide—Sensory loss—Memantine—Alzheimer's disease	0.00197	0.00717	CcSEcCtD
Disopyramide—Apnoea—Rivastigmine—Alzheimer's disease	0.00197	0.00717	CcSEcCtD
Disopyramide—Atrioventricular block—Donepezil—Alzheimer's disease	0.00194	0.00705	CcSEcCtD
Disopyramide—KCND2—brain—Alzheimer's disease	0.00189	0.0287	CbGeAlD
Disopyramide—CHRM2—telencephalon—Alzheimer's disease	0.00187	0.0284	CbGeAlD
Disopyramide—CHRM1—forebrain—Alzheimer's disease	0.00185	0.0281	CbGeAlD
Disopyramide—SLC22A1—telencephalon—Alzheimer's disease	0.00184	0.0279	CbGeAlD
Disopyramide—Hepatic enzyme increased—Memantine—Alzheimer's disease	0.0018	0.00656	CcSEcCtD
Disopyramide—Hypercholesterolaemia—Memantine—Alzheimer's disease	0.0018	0.00656	CcSEcCtD
Disopyramide—Cardiac failure—Galantamine—Alzheimer's disease	0.0018	0.00656	CcSEcCtD
Disopyramide—Creatinine increased—Memantine—Alzheimer's disease	0.00179	0.00652	CcSEcCtD
Disopyramide—Blood urea increased—Donepezil—Alzheimer's disease	0.00177	0.00646	CcSEcCtD
Disopyramide—Hypercholesterolaemia—Rivastigmine—Alzheimer's disease	0.00177	0.00642	CcSEcCtD
Disopyramide—Atrioventricular block—Memantine—Alzheimer's disease	0.00176	0.0064	CcSEcCtD
Disopyramide—Dry eye—Donepezil—Alzheimer's disease	0.00174	0.00632	CcSEcCtD
Disopyramide—Atrioventricular block—Rivastigmine—Alzheimer's disease	0.00172	0.00626	CcSEcCtD
Disopyramide—CHRM1—telencephalon—Alzheimer's disease	0.0017	0.0258	CbGeAlD
Disopyramide—Urinary retention—Galantamine—Alzheimer's disease	0.00167	0.00609	CcSEcCtD
Disopyramide—CHRM3—forebrain—Alzheimer's disease	0.00166	0.0251	CbGeAlD
Disopyramide—KCND3—brain—Alzheimer's disease	0.00165	0.0251	CbGeAlD
Disopyramide—Blood urea increased—Memantine—Alzheimer's disease	0.00161	0.00586	CcSEcCtD
Disopyramide—Abdominal pain upper—Galantamine—Alzheimer's disease	0.00161	0.00585	CcSEcCtD
Disopyramide—Hypokalaemia—Galantamine—Alzheimer's disease	0.0016	0.00583	CcSEcCtD
Disopyramide—Coma—Memantine—Alzheimer's disease	0.00156	0.00567	CcSEcCtD
Disopyramide—Muscular weakness—Galantamine—Alzheimer's disease	0.00155	0.00565	CcSEcCtD
Disopyramide—Coma—Rivastigmine—Alzheimer's disease	0.00153	0.00555	CcSEcCtD
Disopyramide—CHRM3—telencephalon—Alzheimer's disease	0.00152	0.0231	CbGeAlD
Disopyramide—Cardiac failure congestive—Donepezil—Alzheimer's disease	0.0015	0.00547	CcSEcCtD
Disopyramide—Pollakiuria—Galantamine—Alzheimer's disease	0.00141	0.00511	CcSEcCtD
Disopyramide—Cardiac failure—Donepezil—Alzheimer's disease	0.0014	0.00509	CcSEcCtD
Disopyramide—Hypoglycaemia—Donepezil—Alzheimer's disease	0.0014	0.00509	CcSEcCtD
Disopyramide—Cardiac failure congestive—Memantine—Alzheimer's disease	0.00137	0.00497	CcSEcCtD
Disopyramide—Depression—Galantamine—Alzheimer's disease	0.00135	0.00492	CcSEcCtD
Disopyramide—Psychotic disorder—Donepezil—Alzheimer's disease	0.00133	0.00485	CcSEcCtD
Disopyramide—Urinary retention—Donepezil—Alzheimer's disease	0.0013	0.00472	CcSEcCtD
Disopyramide—SCN5A—nervous system—Alzheimer's disease	0.0013	0.0197	CbGeAlD
Disopyramide—Blood creatinine increased—Donepezil—Alzheimer's disease	0.00128	0.00465	CcSEcCtD
Disopyramide—Hypoglycaemia—Memantine—Alzheimer's disease	0.00127	0.00462	CcSEcCtD
Disopyramide—Cardiac failure—Memantine—Alzheimer's disease	0.00127	0.00462	CcSEcCtD
Disopyramide—SCN5A—central nervous system—Alzheimer's disease	0.00125	0.019	CbGeAlD
Disopyramide—Abdominal pain upper—Donepezil—Alzheimer's disease	0.00125	0.00453	CcSEcCtD
Disopyramide—Hypoglycaemia—Rivastigmine—Alzheimer's disease	0.00124	0.00452	CcSEcCtD
Disopyramide—Cardiac failure—Rivastigmine—Alzheimer's disease	0.00124	0.00452	CcSEcCtD
Disopyramide—Hypokalaemia—Donepezil—Alzheimer's disease	0.00124	0.00452	CcSEcCtD
Disopyramide—Bradycardia—Galantamine—Alzheimer's disease	0.00124	0.00451	CcSEcCtD
Disopyramide—Diplopia—Memantine—Alzheimer's disease	0.00124	0.00451	CcSEcCtD
Disopyramide—Hepatitis—Galantamine—Alzheimer's disease	0.00122	0.00443	CcSEcCtD
Disopyramide—Diplopia—Rivastigmine—Alzheimer's disease	0.00121	0.00441	CcSEcCtD
Disopyramide—Psychotic disorder—Memantine—Alzheimer's disease	0.00121	0.0044	CcSEcCtD
Disopyramide—Muscular weakness—Donepezil—Alzheimer's disease	0.0012	0.00438	CcSEcCtD
Disopyramide—Abdominal distension—Donepezil—Alzheimer's disease	0.00119	0.00432	CcSEcCtD
Disopyramide—Psychotic disorder—Rivastigmine—Alzheimer's disease	0.00118	0.00431	CcSEcCtD
Disopyramide—ORM1—nervous system—Alzheimer's disease	0.00118	0.018	CbGeAlD
Disopyramide—Cardiac arrest—Memantine—Alzheimer's disease	0.00118	0.00429	CcSEcCtD
Disopyramide—Urinary retention—Memantine—Alzheimer's disease	0.00118	0.00429	CcSEcCtD
Disopyramide—Blood creatinine increased—Memantine—Alzheimer's disease	0.00116	0.00422	CcSEcCtD
Disopyramide—Cardiac arrest—Rivastigmine—Alzheimer's disease	0.00115	0.00419	CcSEcCtD
Disopyramide—Urinary retention—Rivastigmine—Alzheimer's disease	0.00115	0.00419	CcSEcCtD
Disopyramide—Sweating increased—Donepezil—Alzheimer's disease	0.00115	0.00418	CcSEcCtD
Disopyramide—ORM1—central nervous system—Alzheimer's disease	0.00114	0.0173	CbGeAlD
Disopyramide—Hypokalaemia—Memantine—Alzheimer's disease	0.00113	0.0041	CcSEcCtD
Disopyramide—Abdominal pain upper—Rivastigmine—Alzheimer's disease	0.00111	0.00403	CcSEcCtD
Disopyramide—CHRM2—nervous system—Alzheimer's disease	0.0011	0.0168	CbGeAlD
Disopyramide—Hypokalaemia—Rivastigmine—Alzheimer's disease	0.0011	0.00401	CcSEcCtD
Disopyramide—Dysuria—Donepezil—Alzheimer's disease	0.0011	0.00401	CcSEcCtD
Disopyramide—Muscular weakness—Memantine—Alzheimer's disease	0.00109	0.00398	CcSEcCtD
Disopyramide—Pollakiuria—Donepezil—Alzheimer's disease	0.00109	0.00396	CcSEcCtD
Disopyramide—Arrhythmia—Galantamine—Alzheimer's disease	0.00109	0.00396	CcSEcCtD
Disopyramide—SLC22A1—nervous system—Alzheimer's disease	0.00108	0.0165	CbGeAlD
Disopyramide—Weight increased—Donepezil—Alzheimer's disease	0.00107	0.0039	CcSEcCtD
Disopyramide—Muscular weakness—Rivastigmine—Alzheimer's disease	0.00107	0.00389	CcSEcCtD
Disopyramide—CHRM2—central nervous system—Alzheimer's disease	0.00106	0.0161	CbGeAlD
Disopyramide—Depression—Donepezil—Alzheimer's disease	0.00105	0.00381	CcSEcCtD
Disopyramide—Flatulence—Galantamine—Alzheimer's disease	0.00104	0.0038	CcSEcCtD
Disopyramide—SLC22A1—central nervous system—Alzheimer's disease	0.00104	0.0158	CbGeAlD
Disopyramide—Sweating increased—Memantine—Alzheimer's disease	0.00104	0.00379	CcSEcCtD
Disopyramide—Tension—Galantamine—Alzheimer's disease	0.00104	0.00379	CcSEcCtD
Disopyramide—Dysgeusia—Galantamine—Alzheimer's disease	0.00104	0.00378	CcSEcCtD
Disopyramide—Nervousness—Galantamine—Alzheimer's disease	0.00103	0.00375	CcSEcCtD
Disopyramide—Sweating increased—Rivastigmine—Alzheimer's disease	0.00102	0.00371	CcSEcCtD
Disopyramide—CHRM1—nervous system—Alzheimer's disease	0.001	0.0153	CbGeAlD
Disopyramide—Dysuria—Memantine—Alzheimer's disease	0.001	0.00364	CcSEcCtD
Disopyramide—Neutropenia—Memantine—Alzheimer's disease	0.001	0.00364	CcSEcCtD
Disopyramide—Vision blurred—Galantamine—Alzheimer's disease	0.000999	0.00364	CcSEcCtD
Disopyramide—SCN5A—brain—Alzheimer's disease	0.000991	0.015	CbGeAlD
Disopyramide—Pollakiuria—Memantine—Alzheimer's disease	0.000989	0.0036	CcSEcCtD
Disopyramide—Erectile dysfunction—Memantine—Alzheimer's disease	0.000986	0.00359	CcSEcCtD
Disopyramide—Ill-defined disorder—Galantamine—Alzheimer's disease	0.000984	0.00358	CcSEcCtD
Disopyramide—Dysuria—Rivastigmine—Alzheimer's disease	0.000979	0.00356	CcSEcCtD
Disopyramide—Weight increased—Memantine—Alzheimer's disease	0.000974	0.00355	CcSEcCtD
Disopyramide—Pollakiuria—Rivastigmine—Alzheimer's disease	0.000968	0.00352	CcSEcCtD
Disopyramide—CHRM1—central nervous system—Alzheimer's disease	0.000967	0.0147	CbGeAlD
Disopyramide—Erectile dysfunction—Rivastigmine—Alzheimer's disease	0.000965	0.00351	CcSEcCtD
Disopyramide—Bradycardia—Donepezil—Alzheimer's disease	0.000961	0.0035	CcSEcCtD
Disopyramide—Malaise—Galantamine—Alzheimer's disease	0.000956	0.00348	CcSEcCtD
Disopyramide—Weight increased—Rivastigmine—Alzheimer's disease	0.000953	0.00347	CcSEcCtD
Disopyramide—Vertigo—Galantamine—Alzheimer's disease	0.000953	0.00347	CcSEcCtD
Disopyramide—Depression—Memantine—Alzheimer's disease	0.000952	0.00346	CcSEcCtD
Disopyramide—Syncope—Galantamine—Alzheimer's disease	0.000951	0.00346	CcSEcCtD
Disopyramide—Hepatitis—Donepezil—Alzheimer's disease	0.000944	0.00343	CcSEcCtD
Disopyramide—Hypoaesthesia—Donepezil—Alzheimer's disease	0.000939	0.00342	CcSEcCtD
Disopyramide—Drowsiness—Rivastigmine—Alzheimer's disease	0.000934	0.0034	CcSEcCtD
Disopyramide—Loss of consciousness—Galantamine—Alzheimer's disease	0.000932	0.00339	CcSEcCtD
Disopyramide—Depression—Rivastigmine—Alzheimer's disease	0.000931	0.00339	CcSEcCtD
Disopyramide—Chest pain—Galantamine—Alzheimer's disease	0.000903	0.00328	CcSEcCtD
Disopyramide—CHRM3—nervous system—Alzheimer's disease	0.000899	0.0137	CbGeAlD
Disopyramide—Discomfort—Galantamine—Alzheimer's disease	0.000892	0.00324	CcSEcCtD
Disopyramide—Agranulocytosis—Memantine—Alzheimer's disease	0.000891	0.00324	CcSEcCtD
Disopyramide—Dry mouth—Galantamine—Alzheimer's disease	0.000883	0.00321	CcSEcCtD
Disopyramide—Confusional state—Galantamine—Alzheimer's disease	0.000872	0.00317	CcSEcCtD
Disopyramide—Bradycardia—Memantine—Alzheimer's disease	0.000872	0.00317	CcSEcCtD
Disopyramide—Fesoterodine—CYP2D6—Alzheimer's disease	0.000871	0.394	CrCbGaD
Disopyramide—CHRM3—central nervous system—Alzheimer's disease	0.000865	0.0131	CbGeAlD
Disopyramide—Hepatitis—Memantine—Alzheimer's disease	0.000857	0.00312	CcSEcCtD
Disopyramide—Bradycardia—Rivastigmine—Alzheimer's disease	0.000854	0.00311	CcSEcCtD
Disopyramide—Hypoaesthesia—Memantine—Alzheimer's disease	0.000853	0.0031	CcSEcCtD
Disopyramide—Shock—Galantamine—Alzheimer's disease	0.000851	0.0031	CcSEcCtD
Disopyramide—Thrombocytopenia—Galantamine—Alzheimer's disease	0.000847	0.00308	CcSEcCtD
Disopyramide—CHRM2—brain—Alzheimer's disease	0.000843	0.0128	CbGeAlD
Disopyramide—Arrhythmia—Donepezil—Alzheimer's disease	0.000843	0.00307	CcSEcCtD
Disopyramide—Skin disorder—Galantamine—Alzheimer's disease	0.00084	0.00306	CcSEcCtD
Disopyramide—Hepatitis—Rivastigmine—Alzheimer's disease	0.000838	0.00305	CcSEcCtD
Disopyramide—Hyperhidrosis—Galantamine—Alzheimer's disease	0.000836	0.00304	CcSEcCtD
Disopyramide—Hypoaesthesia—Rivastigmine—Alzheimer's disease	0.000834	0.00304	CcSEcCtD
Disopyramide—SLC22A1—brain—Alzheimer's disease	0.000828	0.0126	CbGeAlD
Disopyramide—Anorexia—Galantamine—Alzheimer's disease	0.000825	0.003	CcSEcCtD
Disopyramide—Flatulence—Donepezil—Alzheimer's disease	0.00081	0.00295	CcSEcCtD
Disopyramide—Hypotension—Galantamine—Alzheimer's disease	0.000809	0.00294	CcSEcCtD
Disopyramide—Tension—Donepezil—Alzheimer's disease	0.000806	0.00293	CcSEcCtD
Disopyramide—Dysgeusia—Donepezil—Alzheimer's disease	0.000805	0.00293	CcSEcCtD
Disopyramide—Nervousness—Donepezil—Alzheimer's disease	0.000798	0.0029	CcSEcCtD
Disopyramide—Insomnia—Galantamine—Alzheimer's disease	0.000783	0.00285	CcSEcCtD
Disopyramide—Paraesthesia—Galantamine—Alzheimer's disease	0.000777	0.00283	CcSEcCtD
Disopyramide—Vision blurred—Donepezil—Alzheimer's disease	0.000774	0.00282	CcSEcCtD
Disopyramide—Somnolence—Galantamine—Alzheimer's disease	0.000769	0.0028	CcSEcCtD
Disopyramide—CHRM1—brain—Alzheimer's disease	0.000768	0.0117	CbGeAlD
Disopyramide—Arrhythmia—Memantine—Alzheimer's disease	0.000766	0.00279	CcSEcCtD
Disopyramide—Ill-defined disorder—Donepezil—Alzheimer's disease	0.000762	0.00277	CcSEcCtD
Disopyramide—Dyspepsia—Galantamine—Alzheimer's disease	0.000762	0.00277	CcSEcCtD
Disopyramide—Decreased appetite—Galantamine—Alzheimer's disease	0.000752	0.00274	CcSEcCtD
Disopyramide—Arrhythmia—Rivastigmine—Alzheimer's disease	0.000749	0.00273	CcSEcCtD
Disopyramide—Fatigue—Galantamine—Alzheimer's disease	0.000746	0.00271	CcSEcCtD
Disopyramide—Malaise—Donepezil—Alzheimer's disease	0.000741	0.0027	CcSEcCtD
Disopyramide—Constipation—Galantamine—Alzheimer's disease	0.00074	0.00269	CcSEcCtD
Disopyramide—Vertigo—Donepezil—Alzheimer's disease	0.000738	0.00269	CcSEcCtD
Disopyramide—Syncope—Donepezil—Alzheimer's disease	0.000737	0.00268	CcSEcCtD
Disopyramide—Flatulence—Memantine—Alzheimer's disease	0.000735	0.00267	CcSEcCtD
Disopyramide—Tension—Memantine—Alzheimer's disease	0.000732	0.00266	CcSEcCtD
Disopyramide—Dysgeusia—Memantine—Alzheimer's disease	0.000731	0.00266	CcSEcCtD
Disopyramide—Nervousness—Memantine—Alzheimer's disease	0.000725	0.00264	CcSEcCtD
Disopyramide—Loss of consciousness—Donepezil—Alzheimer's disease	0.000722	0.00263	CcSEcCtD
Disopyramide—Flatulence—Rivastigmine—Alzheimer's disease	0.000719	0.00262	CcSEcCtD
Disopyramide—Tension—Rivastigmine—Alzheimer's disease	0.000716	0.00261	CcSEcCtD
Disopyramide—Dysgeusia—Rivastigmine—Alzheimer's disease	0.000715	0.0026	CcSEcCtD
Disopyramide—Feeling abnormal—Galantamine—Alzheimer's disease	0.000713	0.00259	CcSEcCtD
Disopyramide—Nervousness—Rivastigmine—Alzheimer's disease	0.000709	0.00258	CcSEcCtD
Disopyramide—Vision blurred—Memantine—Alzheimer's disease	0.000703	0.00256	CcSEcCtD
Disopyramide—Chest pain—Donepezil—Alzheimer's disease	0.0007	0.00255	CcSEcCtD
Disopyramide—Ill-defined disorder—Memantine—Alzheimer's disease	0.000692	0.00252	CcSEcCtD
Disopyramide—Discomfort—Donepezil—Alzheimer's disease	0.000691	0.00251	CcSEcCtD
Disopyramide—Vision blurred—Rivastigmine—Alzheimer's disease	0.000688	0.0025	CcSEcCtD
Disopyramide—CHRM3—brain—Alzheimer's disease	0.000687	0.0104	CbGeAlD
Disopyramide—Dry mouth—Donepezil—Alzheimer's disease	0.000684	0.00249	CcSEcCtD
Disopyramide—Body temperature increased—Galantamine—Alzheimer's disease	0.000684	0.00249	CcSEcCtD
Disopyramide—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.000677	0.00246	CcSEcCtD
Disopyramide—Confusional state—Donepezil—Alzheimer's disease	0.000676	0.00246	CcSEcCtD
Disopyramide—Malaise—Memantine—Alzheimer's disease	0.000673	0.00245	CcSEcCtD
Disopyramide—Oedema—Donepezil—Alzheimer's disease	0.000671	0.00244	CcSEcCtD
Disopyramide—Vertigo—Memantine—Alzheimer's disease	0.00067	0.00244	CcSEcCtD
Disopyramide—Syncope—Memantine—Alzheimer's disease	0.000669	0.00243	CcSEcCtD
Disopyramide—Shock—Donepezil—Alzheimer's disease	0.00066	0.0024	CcSEcCtD
Disopyramide—Malaise—Rivastigmine—Alzheimer's disease	0.000658	0.00239	CcSEcCtD
Disopyramide—Thrombocytopenia—Donepezil—Alzheimer's disease	0.000657	0.00239	CcSEcCtD
Disopyramide—Vertigo—Rivastigmine—Alzheimer's disease	0.000656	0.00239	CcSEcCtD
Disopyramide—Loss of consciousness—Memantine—Alzheimer's disease	0.000656	0.00239	CcSEcCtD
Disopyramide—Syncope—Rivastigmine—Alzheimer's disease	0.000655	0.00238	CcSEcCtD
Disopyramide—Hyperhidrosis—Donepezil—Alzheimer's disease	0.000648	0.00236	CcSEcCtD
Disopyramide—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.000641	0.00233	CcSEcCtD
Disopyramide—Anorexia—Donepezil—Alzheimer's disease	0.000639	0.00233	CcSEcCtD
Disopyramide—Chest pain—Memantine—Alzheimer's disease	0.000635	0.00231	CcSEcCtD
Disopyramide—Discomfort—Memantine—Alzheimer's disease	0.000628	0.00228	CcSEcCtD
Disopyramide—Hypotension—Donepezil—Alzheimer's disease	0.000627	0.00228	CcSEcCtD
Disopyramide—Chest pain—Rivastigmine—Alzheimer's disease	0.000621	0.00226	CcSEcCtD
Disopyramide—Dry mouth—Memantine—Alzheimer's disease	0.000621	0.00226	CcSEcCtD
Disopyramide—Asthenia—Galantamine—Alzheimer's disease	0.000621	0.00226	CcSEcCtD
Disopyramide—Confusional state—Memantine—Alzheimer's disease	0.000614	0.00223	CcSEcCtD
Disopyramide—Discomfort—Rivastigmine—Alzheimer's disease	0.000614	0.00223	CcSEcCtD
Disopyramide—Oedema—Memantine—Alzheimer's disease	0.000609	0.00222	CcSEcCtD
Disopyramide—Dry mouth—Rivastigmine—Alzheimer's disease	0.000608	0.00221	CcSEcCtD
Disopyramide—Insomnia—Donepezil—Alzheimer's disease	0.000607	0.00221	CcSEcCtD
Disopyramide—Paraesthesia—Donepezil—Alzheimer's disease	0.000602	0.00219	CcSEcCtD
Disopyramide—Confusional state—Rivastigmine—Alzheimer's disease	0.000601	0.00219	CcSEcCtD
Disopyramide—Shock—Memantine—Alzheimer's disease	0.000599	0.00218	CcSEcCtD
Disopyramide—Dyspnoea—Donepezil—Alzheimer's disease	0.000598	0.00218	CcSEcCtD
Disopyramide—Somnolence—Donepezil—Alzheimer's disease	0.000596	0.00217	CcSEcCtD
Disopyramide—Thrombocytopenia—Memantine—Alzheimer's disease	0.000596	0.00217	CcSEcCtD
Disopyramide—Oedema—Rivastigmine—Alzheimer's disease	0.000596	0.00217	CcSEcCtD
Disopyramide—Diarrhoea—Galantamine—Alzheimer's disease	0.000592	0.00215	CcSEcCtD
Disopyramide—Skin disorder—Memantine—Alzheimer's disease	0.000591	0.00215	CcSEcCtD
Disopyramide—Dyspepsia—Donepezil—Alzheimer's disease	0.00059	0.00215	CcSEcCtD
Disopyramide—Hyperhidrosis—Memantine—Alzheimer's disease	0.000589	0.00214	CcSEcCtD
Disopyramide—Shock—Rivastigmine—Alzheimer's disease	0.000586	0.00213	CcSEcCtD
Disopyramide—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.000583	0.00212	CcSEcCtD
Disopyramide—Decreased appetite—Donepezil—Alzheimer's disease	0.000583	0.00212	CcSEcCtD
Disopyramide—Anorexia—Memantine—Alzheimer's disease	0.00058	0.00211	CcSEcCtD
Disopyramide—Skin disorder—Rivastigmine—Alzheimer's disease	0.000579	0.00211	CcSEcCtD
Disopyramide—Fatigue—Donepezil—Alzheimer's disease	0.000578	0.0021	CcSEcCtD
Disopyramide—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.000576	0.0021	CcSEcCtD
Disopyramide—Pain—Donepezil—Alzheimer's disease	0.000573	0.00209	CcSEcCtD
Disopyramide—Constipation—Donepezil—Alzheimer's disease	0.000573	0.00209	CcSEcCtD
Disopyramide—Dizziness—Galantamine—Alzheimer's disease	0.000572	0.00208	CcSEcCtD
Disopyramide—Hypotension—Memantine—Alzheimer's disease	0.000569	0.00207	CcSEcCtD
Disopyramide—Anorexia—Rivastigmine—Alzheimer's disease	0.000568	0.00207	CcSEcCtD
Disopyramide—Hypotension—Rivastigmine—Alzheimer's disease	0.000557	0.00203	CcSEcCtD
Disopyramide—Feeling abnormal—Donepezil—Alzheimer's disease	0.000553	0.00201	CcSEcCtD
Disopyramide—Insomnia—Memantine—Alzheimer's disease	0.000551	0.002	CcSEcCtD
Disopyramide—Vomiting—Galantamine—Alzheimer's disease	0.00055	0.002	CcSEcCtD
Disopyramide—Paraesthesia—Memantine—Alzheimer's disease	0.000547	0.00199	CcSEcCtD
Disopyramide—Rash—Galantamine—Alzheimer's disease	0.000546	0.00198	CcSEcCtD
Disopyramide—Dermatitis—Galantamine—Alzheimer's disease	0.000545	0.00198	CcSEcCtD
Disopyramide—Dyspnoea—Memantine—Alzheimer's disease	0.000543	0.00198	CcSEcCtD
Disopyramide—Headache—Galantamine—Alzheimer's disease	0.000542	0.00197	CcSEcCtD
Disopyramide—Somnolence—Memantine—Alzheimer's disease	0.000541	0.00197	CcSEcCtD
Disopyramide—Insomnia—Rivastigmine—Alzheimer's disease	0.000539	0.00196	CcSEcCtD
Disopyramide—Dyspepsia—Memantine—Alzheimer's disease	0.000536	0.00195	CcSEcCtD
Disopyramide—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000535	0.00195	CcSEcCtD
Disopyramide—Urticaria—Donepezil—Alzheimer's disease	0.000533	0.00194	CcSEcCtD
Disopyramide—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000531	0.00193	CcSEcCtD
Disopyramide—Body temperature increased—Donepezil—Alzheimer's disease	0.00053	0.00193	CcSEcCtD
Disopyramide—Somnolence—Rivastigmine—Alzheimer's disease	0.00053	0.00193	CcSEcCtD
Disopyramide—Decreased appetite—Memantine—Alzheimer's disease	0.000529	0.00193	CcSEcCtD
Disopyramide—Fatigue—Memantine—Alzheimer's disease	0.000525	0.00191	CcSEcCtD
Disopyramide—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000524	0.00191	CcSEcCtD
Disopyramide—Constipation—Memantine—Alzheimer's disease	0.000521	0.00189	CcSEcCtD
Disopyramide—Pain—Memantine—Alzheimer's disease	0.000521	0.00189	CcSEcCtD
Disopyramide—Decreased appetite—Rivastigmine—Alzheimer's disease	0.000518	0.00188	CcSEcCtD
Disopyramide—Nausea—Galantamine—Alzheimer's disease	0.000514	0.00187	CcSEcCtD
Disopyramide—Fatigue—Rivastigmine—Alzheimer's disease	0.000514	0.00187	CcSEcCtD
Disopyramide—Constipation—Rivastigmine—Alzheimer's disease	0.000509	0.00185	CcSEcCtD
Disopyramide—Pain—Rivastigmine—Alzheimer's disease	0.000509	0.00185	CcSEcCtD
Disopyramide—Feeling abnormal—Memantine—Alzheimer's disease	0.000502	0.00183	CcSEcCtD
Disopyramide—CYP3A4—nervous system—Alzheimer's disease	0.000494	0.0075	CbGeAlD
Disopyramide—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000491	0.00179	CcSEcCtD
Disopyramide—Tripelennamine—CYP2D6—Alzheimer's disease	0.000488	0.221	CrCbGaD
Disopyramide—Urticaria—Memantine—Alzheimer's disease	0.000484	0.00176	CcSEcCtD
Disopyramide—Body temperature increased—Memantine—Alzheimer's disease	0.000481	0.00175	CcSEcCtD
Disopyramide—Asthenia—Donepezil—Alzheimer's disease	0.000481	0.00175	CcSEcCtD
Disopyramide—CYP3A4—central nervous system—Alzheimer's disease	0.000475	0.00722	CbGeAlD
Disopyramide—Pruritus—Donepezil—Alzheimer's disease	0.000474	0.00173	CcSEcCtD
Disopyramide—Urticaria—Rivastigmine—Alzheimer's disease	0.000473	0.00172	CcSEcCtD
Disopyramide—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000471	0.00171	CcSEcCtD
Disopyramide—Diarrhoea—Donepezil—Alzheimer's disease	0.000459	0.00167	CcSEcCtD
Disopyramide—Dizziness—Donepezil—Alzheimer's disease	0.000443	0.00161	CcSEcCtD
Disopyramide—Asthenia—Memantine—Alzheimer's disease	0.000437	0.00159	CcSEcCtD
Disopyramide—Pruritus—Memantine—Alzheimer's disease	0.000431	0.00157	CcSEcCtD
Disopyramide—Asthenia—Rivastigmine—Alzheimer's disease	0.000427	0.00155	CcSEcCtD
Disopyramide—Vomiting—Donepezil—Alzheimer's disease	0.000426	0.00155	CcSEcCtD
Disopyramide—Rash—Donepezil—Alzheimer's disease	0.000423	0.00154	CcSEcCtD
Disopyramide—Dermatitis—Donepezil—Alzheimer's disease	0.000422	0.00154	CcSEcCtD
Disopyramide—Pruritus—Rivastigmine—Alzheimer's disease	0.000421	0.00153	CcSEcCtD
Disopyramide—Headache—Donepezil—Alzheimer's disease	0.00042	0.00153	CcSEcCtD
Disopyramide—Diarrhoea—Memantine—Alzheimer's disease	0.000417	0.00152	CcSEcCtD
Disopyramide—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000408	0.00148	CcSEcCtD
Disopyramide—Dizziness—Memantine—Alzheimer's disease	0.000403	0.00146	CcSEcCtD
Disopyramide—Nausea—Donepezil—Alzheimer's disease	0.000398	0.00145	CcSEcCtD
Disopyramide—Dizziness—Rivastigmine—Alzheimer's disease	0.000394	0.00143	CcSEcCtD
Disopyramide—Tolterodine—CYP2D6—Alzheimer's disease	0.000389	0.176	CrCbGaD
Disopyramide—Vomiting—Memantine—Alzheimer's disease	0.000387	0.00141	CcSEcCtD
Disopyramide—Rash—Memantine—Alzheimer's disease	0.000384	0.0014	CcSEcCtD
Disopyramide—Dermatitis—Memantine—Alzheimer's disease	0.000384	0.0014	CcSEcCtD
Disopyramide—Headache—Memantine—Alzheimer's disease	0.000381	0.00139	CcSEcCtD
Disopyramide—Vomiting—Rivastigmine—Alzheimer's disease	0.000379	0.00138	CcSEcCtD
Disopyramide—Rash—Rivastigmine—Alzheimer's disease	0.000376	0.00137	CcSEcCtD
Disopyramide—Dermatitis—Rivastigmine—Alzheimer's disease	0.000375	0.00137	CcSEcCtD
Disopyramide—Headache—Rivastigmine—Alzheimer's disease	0.000373	0.00136	CcSEcCtD
Disopyramide—Nausea—Memantine—Alzheimer's disease	0.000362	0.00132	CcSEcCtD
Disopyramide—Nausea—Rivastigmine—Alzheimer's disease	0.000354	0.00129	CcSEcCtD
Disopyramide—Dextropropoxyphene—CYP2D6—Alzheimer's disease	0.000274	0.124	CrCbGaD
Disopyramide—Methadone—CYP2D6—Alzheimer's disease	0.000186	0.0842	CrCbGaD
Disopyramide—SCN5A—Developmental Biology—IL6—Alzheimer's disease	2.27e-05	0.000225	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—BCHE—Alzheimer's disease	2.27e-05	0.000224	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—PRKCG—Alzheimer's disease	2.26e-05	0.000223	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—ENO1—Alzheimer's disease	2.25e-05	0.000223	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—PTGS1—Alzheimer's disease	2.25e-05	0.000223	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—PSEN2—Alzheimer's disease	2.24e-05	0.000222	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—PSEN2—Alzheimer's disease	2.24e-05	0.000222	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—ABCA1—Alzheimer's disease	2.22e-05	0.00022	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—PSEN2—Alzheimer's disease	2.22e-05	0.000219	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—ATP5A1—Alzheimer's disease	2.21e-05	0.000219	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—CYP2D6—Alzheimer's disease	2.21e-05	0.000219	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—CCR5—Alzheimer's disease	2.17e-05	0.000214	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—CCR5—Alzheimer's disease	2.16e-05	0.000214	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—PLCB1—Alzheimer's disease	2.14e-05	0.000212	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—CCR5—Alzheimer's disease	2.14e-05	0.000212	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—HTR2A—Alzheimer's disease	2.12e-05	0.00021	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—HTR2A—Alzheimer's disease	2.11e-05	0.000209	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—PLD3—Alzheimer's disease	2.11e-05	0.000209	CbGpPWpGaD
Disopyramide—SCN5A—Developmental Biology—AKT1—Alzheimer's disease	2.09e-05	0.000207	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—BCHE—Alzheimer's disease	2.09e-05	0.000207	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—HTR2A—Alzheimer's disease	2.09e-05	0.000207	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—PRKCG—Alzheimer's disease	2.08e-05	0.000205	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—ABCA1—Alzheimer's disease	2.07e-05	0.000205	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—PRKCG—Alzheimer's disease	2.07e-05	0.000205	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—NPY—Alzheimer's disease	2.07e-05	0.000205	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—NPY—Alzheimer's disease	2.06e-05	0.000204	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—IAPP—Alzheimer's disease	2.05e-05	0.000203	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—PRKCG—Alzheimer's disease	2.05e-05	0.000203	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—IAPP—Alzheimer's disease	2.05e-05	0.000203	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—NPY—Alzheimer's disease	2.04e-05	0.000202	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—IAPP—Alzheimer's disease	2.03e-05	0.000201	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—HSD17B10—Alzheimer's disease	2.02e-05	0.0002	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—CRH—Alzheimer's disease	1.99e-05	0.000197	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—CRH—Alzheimer's disease	1.99e-05	0.000197	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—PLCB1—Alzheimer's disease	1.98e-05	0.000196	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—CRH—Alzheimer's disease	1.97e-05	0.000195	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—CCR5—Alzheimer's disease	1.97e-05	0.000195	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—CCR5—Alzheimer's disease	1.96e-05	0.000194	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—CYP46A1—Alzheimer's disease	1.95e-05	0.000193	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—CCR5—Alzheimer's disease	1.94e-05	0.000192	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—HTR2A—Alzheimer's disease	1.92e-05	0.000191	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—HTR2A—Alzheimer's disease	1.92e-05	0.00019	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—PPARGC1A—Alzheimer's disease	1.92e-05	0.00019	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—ABCA1—Alzheimer's disease	1.92e-05	0.00019	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—HMOX1—Alzheimer's disease	1.91e-05	0.000189	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—HTR2A—Alzheimer's disease	1.9e-05	0.000188	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—NPS—Alzheimer's disease	1.89e-05	0.000187	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—NPS—Alzheimer's disease	1.88e-05	0.000186	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—ND1—Alzheimer's disease	1.88e-05	0.000186	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—PPP3CA—Alzheimer's disease	1.88e-05	0.000186	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—PPP3CA—Alzheimer's disease	1.87e-05	0.000186	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—NPS—Alzheimer's disease	1.87e-05	0.000185	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—F2—Alzheimer's disease	1.86e-05	0.000184	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—PPP3CA—Alzheimer's disease	1.86e-05	0.000184	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—PTK2B—Alzheimer's disease	1.85e-05	0.000183	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—F2—Alzheimer's disease	1.85e-05	0.000183	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—PTK2B—Alzheimer's disease	1.85e-05	0.000183	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—F2—Alzheimer's disease	1.83e-05	0.000182	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—PTK2B—Alzheimer's disease	1.83e-05	0.000181	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—GAB2—Alzheimer's disease	1.8e-05	0.000178	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—SST—Alzheimer's disease	1.8e-05	0.000178	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—NTRK2—Alzheimer's disease	1.8e-05	0.000178	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—NTRK2—Alzheimer's disease	1.8e-05	0.000178	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—SST—Alzheimer's disease	1.8e-05	0.000178	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—GAB2—Alzheimer's disease	1.8e-05	0.000178	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—CALM1—Alzheimer's disease	1.8e-05	0.000178	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—CALM1—Alzheimer's disease	1.79e-05	0.000177	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—PPARGC1A—Alzheimer's disease	1.79e-05	0.000177	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—GSK3A—Alzheimer's disease	1.79e-05	0.000177	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—GSK3A—Alzheimer's disease	1.78e-05	0.000176	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—SST—Alzheimer's disease	1.78e-05	0.000176	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—GAB2—Alzheimer's disease	1.78e-05	0.000176	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—NTRK2—Alzheimer's disease	1.78e-05	0.000176	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—HMOX1—Alzheimer's disease	1.78e-05	0.000176	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—CALM1—Alzheimer's disease	1.77e-05	0.000175	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—GSK3A—Alzheimer's disease	1.76e-05	0.000175	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—APP—Alzheimer's disease	1.76e-05	0.000174	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—APP—Alzheimer's disease	1.75e-05	0.000173	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—LPL—Alzheimer's disease	1.75e-05	0.000173	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—APP—Alzheimer's disease	1.73e-05	0.000172	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—F2—Alzheimer's disease	1.69e-05	0.000167	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—F2—Alzheimer's disease	1.68e-05	0.000166	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—F2—Alzheimer's disease	1.67e-05	0.000165	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—PLCB1—Alzheimer's disease	1.66e-05	0.000164	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—PLCB1—Alzheimer's disease	1.65e-05	0.000164	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—PPARGC1A—Alzheimer's disease	1.65e-05	0.000163	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—HMOX1—Alzheimer's disease	1.64e-05	0.000163	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—PLCB1—Alzheimer's disease	1.64e-05	0.000162	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—LPL—Alzheimer's disease	1.63e-05	0.000161	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—MTHFR—Alzheimer's disease	1.57e-05	0.000156	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—NGFR—Alzheimer's disease	1.55e-05	0.000153	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—NGFR—Alzheimer's disease	1.54e-05	0.000153	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—CREB1—Alzheimer's disease	1.54e-05	0.000152	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—CREB1—Alzheimer's disease	1.53e-05	0.000152	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—NGFR—Alzheimer's disease	1.53e-05	0.000151	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—CREB1—Alzheimer's disease	1.52e-05	0.00015	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—ADAM10—Alzheimer's disease	1.51e-05	0.00015	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—ADAM10—Alzheimer's disease	1.51e-05	0.000149	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—CCL2—Alzheimer's disease	1.5e-05	0.000149	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—LPL—Alzheimer's disease	1.5e-05	0.000149	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—CCL2—Alzheimer's disease	1.5e-05	0.000148	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—ADAM10—Alzheimer's disease	1.49e-05	0.000148	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—CCL2—Alzheimer's disease	1.48e-05	0.000147	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—CALM1—Alzheimer's disease	1.47e-05	0.000145	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—MTHFR—Alzheimer's disease	1.47e-05	0.000145	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—APOE—Alzheimer's disease	1.46e-05	0.000145	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—CAV1—Alzheimer's disease	1.45e-05	0.000144	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—S100B—Alzheimer's disease	1.43e-05	0.000141	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—S100B—Alzheimer's disease	1.42e-05	0.000141	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—S100B—Alzheimer's disease	1.41e-05	0.00014	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—CALM1—Alzheimer's disease	1.37e-05	0.000135	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—APOE—Alzheimer's disease	1.36e-05	0.000135	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—IGF2—Alzheimer's disease	1.36e-05	0.000135	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—IGF2—Alzheimer's disease	1.36e-05	0.000134	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—MTHFR—Alzheimer's disease	1.35e-05	0.000134	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—CAV1—Alzheimer's disease	1.35e-05	0.000134	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—IGF2—Alzheimer's disease	1.34e-05	0.000133	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—IGF1R—Alzheimer's disease	1.32e-05	0.00013	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—IGF1R—Alzheimer's disease	1.31e-05	0.00013	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—IGF1R—Alzheimer's disease	1.3e-05	0.000129	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—PPARG—Alzheimer's disease	1.27e-05	0.000126	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—CALM1—Alzheimer's disease	1.26e-05	0.000125	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—LPL—Alzheimer's disease	1.26e-05	0.000125	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—APOE—Alzheimer's disease	1.26e-05	0.000125	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—LPL—Alzheimer's disease	1.26e-05	0.000124	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—INS—Alzheimer's disease	1.25e-05	0.000124	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—MEF2C—Alzheimer's disease	1.25e-05	0.000124	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—CAV1—Alzheimer's disease	1.25e-05	0.000124	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—MEF2C—Alzheimer's disease	1.25e-05	0.000123	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—LPL—Alzheimer's disease	1.24e-05	0.000123	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—MEF2C—Alzheimer's disease	1.23e-05	0.000122	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—PRKCG—Alzheimer's disease	1.23e-05	0.000121	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—PRKCG—Alzheimer's disease	1.22e-05	0.000121	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—CHAT—Alzheimer's disease	1.21e-05	0.00012	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—TPI1—Alzheimer's disease	1.21e-05	0.00012	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—PRKCG—Alzheimer's disease	1.21e-05	0.00012	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—NGF—Alzheimer's disease	1.19e-05	0.000118	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—NGF—Alzheimer's disease	1.19e-05	0.000118	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—PPARG—Alzheimer's disease	1.19e-05	0.000118	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—NGF—Alzheimer's disease	1.18e-05	0.000117	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—INS—Alzheimer's disease	1.17e-05	0.000115	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—MAOB—Alzheimer's disease	1.16e-05	0.000115	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—CCR5—Alzheimer's disease	1.16e-05	0.000115	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—CCR5—Alzheimer's disease	1.16e-05	0.000115	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—CCR5—Alzheimer's disease	1.15e-05	0.000114	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—HTR2A—Alzheimer's disease	1.14e-05	0.000113	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—HTR2A—Alzheimer's disease	1.13e-05	0.000112	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—HTR2A—Alzheimer's disease	1.12e-05	0.000111	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	1.12e-05	0.000111	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—PPARG—Alzheimer's disease	1.1e-05	0.000109	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—NOS3—Alzheimer's disease	1.1e-05	0.000109	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—A2M—Alzheimer's disease	1.08e-05	0.000107	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—INS—Alzheimer's disease	1.08e-05	0.000107	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—CALM1—Alzheimer's disease	1.06e-05	0.000105	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—CALM1—Alzheimer's disease	1.06e-05	0.000105	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—LEP—Alzheimer's disease	1.06e-05	0.000105	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—APOE—Alzheimer's disease	1.06e-05	0.000105	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—LEP—Alzheimer's disease	1.05e-05	0.000104	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—APOE—Alzheimer's disease	1.05e-05	0.000104	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—CAV1—Alzheimer's disease	1.05e-05	0.000104	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—CALM1—Alzheimer's disease	1.05e-05	0.000104	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—CAV1—Alzheimer's disease	1.04e-05	0.000103	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—LEP—Alzheimer's disease	1.04e-05	0.000103	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—APOE—Alzheimer's disease	1.04e-05	0.000103	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—CAV1—Alzheimer's disease	1.03e-05	0.000102	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—NOS3—Alzheimer's disease	1.02e-05	0.000101	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—ESR1—Alzheimer's disease	1.01e-05	9.99e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—ESR1—Alzheimer's disease	1.01e-05	9.96e-05	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—PTGS2—Alzheimer's disease	1e-05	9.93e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—F2—Alzheimer's disease	9.97e-06	9.87e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—ESR1—Alzheimer's disease	9.96e-06	9.86e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—F2—Alzheimer's disease	9.93e-06	9.84e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—F2—Alzheimer's disease	9.84e-06	9.74e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—NOTCH1—Alzheimer's disease	9.75e-06	9.66e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—NOTCH1—Alzheimer's disease	9.72e-06	9.62e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—NOTCH1—Alzheimer's disease	9.63e-06	9.53e-05	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—NOS3—Alzheimer's disease	9.44e-06	9.34e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—ACHE—Alzheimer's disease	9.4e-06	9.3e-05	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—PTGS2—Alzheimer's disease	9.35e-06	9.25e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	9.29e-06	9.2e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—GSK3B—Alzheimer's disease	9.15e-06	9.06e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—GSK3B—Alzheimer's disease	9.12e-06	9.03e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—CREB1—Alzheimer's disease	9.08e-06	8.99e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—CREB1—Alzheimer's disease	9.05e-06	8.96e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—GSK3B—Alzheimer's disease	9.03e-06	8.94e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—INS—Alzheimer's disease	9.03e-06	8.94e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—INS—Alzheimer's disease	9e-06	8.91e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—CREB1—Alzheimer's disease	8.96e-06	8.87e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—INS—Alzheimer's disease	8.91e-06	8.82e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—CCL2—Alzheimer's disease	8.88e-06	8.79e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—CCL2—Alzheimer's disease	8.85e-06	8.77e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—ENO1—Alzheimer's disease	8.81e-06	8.72e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	8.81e-06	8.72e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—CCL2—Alzheimer's disease	8.77e-06	8.68e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—IGF1—Alzheimer's disease	8.73e-06	8.65e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—IGF1—Alzheimer's disease	8.7e-06	8.62e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	8.64e-06	8.55e-05	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—PTGS2—Alzheimer's disease	8.63e-06	8.55e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—IGF1—Alzheimer's disease	8.62e-06	8.53e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—BCHE—Alzheimer's disease	8.19e-06	8.1e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—NOS3—Alzheimer's disease	7.92e-06	7.84e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—NOS3—Alzheimer's disease	7.89e-06	7.81e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—NOS3—Alzheimer's disease	7.82e-06	7.74e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	7.72e-06	7.65e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	7.49e-06	7.41e-05	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—AKT1—Alzheimer's disease	6.78e-06	6.72e-05	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—AKT1—Alzheimer's disease	6.76e-06	6.7e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—CASP3—Alzheimer's disease	6.72e-06	6.65e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—CASP3—Alzheimer's disease	6.7e-06	6.63e-05	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—AKT1—Alzheimer's disease	6.7e-06	6.63e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—IL6—Alzheimer's disease	6.68e-06	6.61e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—IL6—Alzheimer's disease	6.66e-06	6.59e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—CASP3—Alzheimer's disease	6.64e-06	6.57e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—IL6—Alzheimer's disease	6.59e-06	6.53e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	6.45e-06	6.39e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	6.42e-06	6.36e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—MAPK8—Alzheimer's disease	6.18e-06	6.12e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—AKT1—Alzheimer's disease	6.16e-06	6.1e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—MAPK8—Alzheimer's disease	6.16e-06	6.1e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—AKT1—Alzheimer's disease	6.14e-06	6.08e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—MAPK8—Alzheimer's disease	6.1e-06	6.04e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—AKT1—Alzheimer's disease	6.08e-06	6.02e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—LPL—Alzheimer's disease	5.88e-06	5.82e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—VEGFA—Alzheimer's disease	5.7e-06	5.65e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—VEGFA—Alzheimer's disease	5.69e-06	5.63e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—VEGFA—Alzheimer's disease	5.63e-06	5.57e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	5.29e-06	5.24e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—TGFB1—Alzheimer's disease	5.24e-06	5.18e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—TGFB1—Alzheimer's disease	5.22e-06	5.17e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—TGFB1—Alzheimer's disease	5.17e-06	5.12e-05	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—AKT1—Alzheimer's disease	5.04e-06	4.99e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—CALM1—Alzheimer's disease	4.94e-06	4.89e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—APOE—Alzheimer's disease	4.93e-06	4.88e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—CAV1—Alzheimer's disease	4.88e-06	4.83e-05	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—AKT1—Alzheimer's disease	4.7e-06	4.65e-05	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—AKT1—Alzheimer's disease	4.34e-06	4.3e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—TP53—Alzheimer's disease	4.31e-06	4.27e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—TP53—Alzheimer's disease	4.3e-06	4.25e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—PPARG—Alzheimer's disease	4.29e-06	4.25e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—TP53—Alzheimer's disease	4.25e-06	4.21e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—INS—Alzheimer's disease	4.21e-06	4.17e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—IL6—Alzheimer's disease	3.95e-06	3.91e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—IL6—Alzheimer's disease	3.93e-06	3.89e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—IL6—Alzheimer's disease	3.89e-06	3.86e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—NOS3—Alzheimer's disease	3.69e-06	3.65e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—AKT1—Alzheimer's disease	3.64e-06	3.6e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—AKT1—Alzheimer's disease	3.63e-06	3.59e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—AKT1—Alzheimer's disease	3.59e-06	3.56e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	3.37e-06	3.34e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—AKT1—Alzheimer's disease	1.7e-06	1.68e-05	CbGpPWpGaD
